How to Amend Patent Specification: UK & EPO Pre‑grant vs Post‑grant (2026)

Understanding how to amend patent specification text, whether narrowing claims, correcting errors or adapting to examiner objections, is one of the most consequential procedural skills in UK and European patent practice. The overriding constraint is the prohibition on added matter: under Section 76 of the Patents Act 1977 and Article 123(2) of the European Patent Convention (EPC), no amendment may introduce subject‑matter that extends beyond the content of the application as originally filed. With the UKIPO’s ongoing digital‑transformation programme and evolving EPO examination practice, the tactical choices available to applicants and patentees in 2026 demand careful navigation.

This guide sets out the exact routes, forms, timing windows and risk‑management strategies for pre‑grant and post‑grant amendments at both the UKIPO and the EPO.

At a Glance: Quick Answer and Decision Checklist

Can a patent be amended? Yes. Both pending UK patent applications and granted UK patents can be amended, but every amendment must satisfy the added‑matter test, it must not disclose matter that extends beyond what was in the application as filed. The same principle applies at the EPO under Article 123(2) EPC.

Before requesting any UKIPO patent amendment, work through this five‑point decision checklist:

1. Has the patent been granted yet? If not, follow the pre‑grant route (Section 19, Patents Act 1977). If it has, use the post‑grant route (Section 27 or Section 75).
2. Does the proposed amendment add new subject‑matter? Map every change back to the application as filed. If the amendment is not directly and unambiguously derivable from the original disclosure, it will be refused under added matter Section 76.
3. Which office has jurisdiction? If the patent derives from a European application (EP(UK)), post‑grant amendments may need to go through EPO opposition or limitation proceedings rather than, or as well as, the UKIPO.
4. What forms are required? Pre‑grant amendments at the UKIPO typically use Patents Form 20; corrections of clerical errors may require Patents Form 21.
5. Is litigation pending? If infringement or revocation proceedings are on foot, the court controls amendment rather than the Comptroller.

Legal Rules That Constrain How to Amend Patent Specification Text

Three interlocking legal frameworks govern amendments to patent specifications in UK and European practice. Practitioners must understand the interplay between UK statute, UKIPO procedural rules and the EPC before drafting any request.

Section 76 (UK), Key Points

Section 76 of the Patents Act 1977 provides that no amendment of a patent application or granted patent shall be allowed if it results in the application or patent disclosing additional matter, that is, matter extending beyond what was contained in the application as filed. The Manual of Patent Practice (MOPP) Section 76 elaborates: the test is whether a skilled person, comparing the amended specification with the original, would learn anything new about the invention that was not directly and unambiguously derivable from the original disclosure. Failure to satisfy Section 76 during prosecution means the amendment is refused; if added matter is identified post‑grant, it constitutes a ground for revocation under Section 72(1)(d).

Article 123(2) EPC, Key Points

At the EPO, the equivalent rule is Article 123(2) of the European Patent Convention, which states that a European patent application or patent may not be amended in such a way that it contains subject‑matter which extends beyond the content of the application as filed. The EPO Guidelines for Examination apply this test rigorously: the Boards of Appeal have developed a substantial body of case law requiring that amended features be directly and unambiguously derivable from the original application documents, including drawings. An additional constraint applies post‑grant: Article 123(3) EPC prevents any amendment that broadens the scope of protection conferred by the granted claims.

Practical Differences: UK vs EPO vs US

Area	UKIPO (s.76 / MOPP)	EPO (Art.123(2) / Guidelines)	USPTO (35 U.S.C. § 132 / MPEP)
Legal test for added matter	No matter extending beyond the application as filed (s.76, Patents Act 1977)	No subject‑matter extending beyond content of application as filed (Art.123(2) EPC)	No “new matter”, 35 U.S.C. § 132 prohibits amendments introducing new matter into the disclosure
Pre‑grant amendment window	Section 19, general power to amend before the grant letter issues	During examination proceedings; voluntary amendments possible under Rule 137 EPC	Before and after office actions; post‑allowance via Rule 312 (37 CFR 1.312) with examiner approval
Post‑grant amendment route	Section 27 (Comptroller) or Section 75 (court); subject to s.76 and third‑party opposition	Opposition (Art.101 EPC), limitation (Art.105a EPC), or during appeal	Reissue (35 U.S.C. § 251) or ex parte re‑examination
Practical strictness	Generally considered flexible on intermediate generalisations; UK practice notices guide approach	Strict, narrow interpretation of original disclosure; extensive Board of Appeal case law	Focus on written‑description support; less formal “gold standard” test than EPO

The Patents (Amendment) (No. 2) Rules 2016 updated the procedural mechanics at the UKIPO, including the formal requirements for filing amendments and the associated forms. These rules remain the procedural backbone for how applicants change or update their patent applications and granted patents in 2026 practice.

Pre‑Grant Amendment: Routes, Forms and Timing (UKIPO)

Section 19 of the Patents Act 1977 confers a general power to amend an application before grant, subject to the added‑matter prohibition. According to MOPP Section 19, a request to amend must be received before the issue of the letter informing the applicant that a patent has been granted. In practical terms, this means applicants have until the very last stage of examination to modify claims, the description or drawings, but early and proactive amendments are strongly advisable.

Using Patents Form 20, How and When

Patents Form 20 is the standard form used to request amendments to a pending UK patent application. It accompanies the marked‑up or replacement pages of the specification. Key practical points include:

• Timing. File Form 20 as soon as you identify the need to amend, whether in response to a UKIPO examination report or voluntarily. Amendments filed early in prosecution give the examiner time to assess them without delaying grant.
• What to submit. Include the completed Form 20, a clean copy of the amended pages and a marked‑up copy clearly showing all deletions and insertions. The UKIPO requires that amendments be identifiable at a glance.
• Fees. Check the current UKIPO fee schedule, as fees for certain amendment requests may apply. The UKIPO’s online services portal allows electronic filing of Form 20.
• Examiner response. The examiner will assess whether the amendments comply with Section 76. If they do, the amended text is accepted into the application. If added matter is identified, the examiner issues an objection and invites further amendment or argument.

Correcting Obvious Errors Before Grant

Where an amendment is needed simply to correct an obvious clerical or typographical error, such as a misspelled chemical name or an incorrect reference numeral, Patents Form 21 may be used to request correction under Section 117 of the Patents Act 1977. This route is narrower: the error must be self‑evidently a mistake, and the correction must be obvious to the skilled reader. It is not appropriate for substantive claim amendments.

Best Practices for Claim Amendments

Conducting a thorough UK patent search before amending claims is essential. Reviewing the prior art landscape ensures that any narrowing amendment positions the claims advantageously without conceding more scope than necessary. When drafting amended claims:

• Combine dependent claims. The lowest‑risk amendment strategy is to incorporate the features of a dependent claim into the independent claim. Because these features already appear in the specification as filed, added‑matter risk is minimal.
• Use original wording. Wherever possible, use language drawn verbatim from the description or original claims. Paraphrasing introduces the risk that a new combination of features is created that was not explicitly disclosed.
• Avoid intermediate generalisations. Extracting a single feature from an embodiment described in a specific technical context and presenting it in isolation as a general limitation is a common source of added‑matter objections, particularly at the EPO.
• Track changes meticulously. Always prepare a marked‑up version showing deletions in strikethrough and additions underlined. This is mandatory practice at the UKIPO and facilitates rapid examiner assessment.

Post‑Grant Amendment Routes: UK and EPO Procedures

Once a patent has been granted, the available routes to amend patent specification text become more constrained and procedurally demanding. The rationale is straightforward: third parties have relied on the granted text, and any change to it must be balanced against their legitimate interests.

UK Post‑Grant Techniques

Under Section 27 of the Patents Act 1977, a patentee may apply to the Comptroller to amend a granted patent specification. The Comptroller must advertise the proposed amendments, giving third parties an opportunity to oppose. Section 75 provides the equivalent power to the court where proceedings, typically infringement or revocation actions, are already under way. In both cases:

• Added matter Section 76 applies in full. The amendment must not extend the disclosure beyond the application as filed.
• No broadening. The amendment must not extend the scope of protection conferred by the patent (mirroring Art.123(3) EPC).
• Discretionary factors. The Comptroller or court considers whether there has been unreasonable delay in seeking amendment, whether the patentee has acted in good faith and whether the amendment would prejudice third parties.

Correction of errors in a granted patent is available under Section 117 (clerical errors) and, for errors in patent office procedures, under Section 117A. These routes are narrow and are not a substitute for substantive amendment.

EPO Routes, Opposition, Limitation, Central Revocation

For European patents designating the UK, the EPO offers three main post‑grant mechanisms:

• Opposition proceedings (Article 99 / 101 EPC). Within nine months of grant, any third party may file an opposition. The patentee may amend claims during opposition, but every amendment must satisfy both Article 123(2) (no added matter) and Article 123(3) (no broadening). Industry observers note that the interplay between these two provisions, sometimes called the “inescapable trap”, can leave patentees unable to find a permissible amendment that saves the patent.
• Limitation proceedings (Article 105a EPC). The patentee may request limitation of the European patent at any time after grant (and outside opposition). This route restricts claim scope by amending the claims. It is examined centrally by the EPO, once allowed, the limitation takes effect in all designated states. The procedure is relatively quick and cost‑effective compared with national post‑grant amendment routes.
• Central revocation (Article 105b EPC). The patentee may also request complete revocation of the European patent if it can no longer be maintained in an acceptable form.

Strategic Decision Matrix

Scenario	Recommended Route	Key Considerations
Need to narrow claims across all EP states	EPO limitation (Art.105a)	Fast, central effect; no third‑party opposition stage; must still meet Art.123(2)/(3)
Third party has filed EPO opposition	Defend and file auxiliary requests	Prepare multiple fallback claim sets; map every amendment to original disclosure
UK‑only amendment needed; no litigation pending	Section 27 application to Comptroller	Third parties may oppose; discretionary factors apply; s.76 compliance essential
Amendment needed during UK litigation	Section 75 application to the court	Court controls timing; validity attacks may follow; forensic disclosure mapping required
Obvious error in granted patent	Section 117 correction	Error must be self‑evident; not available for substantive claim changes

Note that patent renewal deadlines are entirely separate from amendment timelines. The grace period for renewing a UK patent after the annual renewal date is six months, subject to a late‑payment surcharge, this has no bearing on the window for filing amendments.

Added‑Matter Risks: Assessing and Avoiding Section 76 and Article 123(2) Pitfalls

Added matter is the single most common reason amendments fail, whether at the UKIPO or the EPO. The principle is deceptively simple, do not disclose anything new, but its application in practice, especially for complex life‑sciences inventions, demands rigorous analysis.

Disclosure Mapping Method

Disclosure mapping is the discipline of tracing every element of the proposed amended text back to a specific passage, claim or drawing in the application as filed. To perform a disclosure map:

1. Identify every changed element. List each new word, deleted passage and restructured sentence in the proposed amendment.
2. Locate the original basis. For each changed element, identify the exact paragraph, claim number or figure in the application as filed that provides explicit support.
3. Assess combinations. If the amendment combines features from different parts of the original disclosure (e.g., a feature from Example 3 with a feature from Claim 1), check whether the combination itself was disclosed as a coherent technical teaching.
4. Apply the skilled‑person test. Ask whether a person skilled in the art, reading the original application, would directly and unambiguously derive the amended disclosure, without needing to make assumptions, inferences or generalisations.
5. Check for implicit disclosures. Drawings, tables and sequence listings form part of the original disclosure. Features clearly and unambiguously derivable from a figure can support an amendment even if not expressly stated in the description.
6. Document the mapping. Create a written record, a two‑column table mapping each amended passage to its original basis, that can be filed as a supporting submission if the examiner raises an added‑matter objection.

Evidence and Supporting Submissions

When added‑matter compliance is borderline, supporting evidence strengthens the case for entry of the amendment. At the UKIPO, applicants may file a covering letter explaining the basis for each amendment with reference to specific paragraphs and figures. At the EPO, applicants responding to an Article 123(2) objection should provide the basis table described above as part of their written submissions. In contentious proceedings such as oppositions, expert declarations addressing what the skilled person would understand from the original disclosure may also be appropriate.

Practical Red‑Amber‑Green Amendment Examples

The following examples, drawn from typical life‑sciences prosecution scenarios, illustrate the spectrum of added‑matter risk when practitioners amend patent specification text:

• Green (low risk). Combining a dependent claim (“wherein the compound is administered at 10 mg/kg”) into the independent claim. Both features were individually disclosed; the combination was presented as an embodiment. This is the safest form of amendment.
• Green (low risk). Deleting an alternative from a Markush group already recited in the claims (e.g., removing one member from “selected from A, B, C and D”), provided no new technical teaching arises from the deletion.
• Amber (moderate risk). Extracting a numerical range endpoint from a worked example and using it as a claim limitation (e.g., “a temperature of at least 37 °C” derived from an example conducted at 37 °C). The EPO may object that selecting this endpoint from a broader disclosed range constitutes an intermediate generalisation, unless 37 °C was presented as having independent technical significance.
• Amber (moderate risk). Replacing a genus with a species in the claims (e.g., “polypeptide” narrowed to “antibody”) where the species is described only in one embodiment alongside several other structural features. Separating the species from its surrounding context risks creating a new disclosure.
• Red (high risk). Introducing a new functional limitation (e.g., “exhibiting enhanced bioavailability”) that does not appear verbatim in the application as filed, even if the described compound would inherently possess that property. The amendment adds new technical information to the disclosure.
• Red (high risk). Combining features from two separate embodiments that were not presented as combinable in the original application (e.g., a dosing regimen from Example 1 with a formulation excipient from Example 4).

UKIPO and EPO Procedural Walkthroughs

The following stepwise checklists summarise how to amend patent specification text at each office. They are designed to be used as practical workflows alongside the legal analysis described above.

UKIPO Stepwise Checklist

1. Review the latest examination report and identify the amendment needed.
2. Perform a disclosure mapping exercise to confirm Section 76 compliance.
3. Prepare a clean copy and a marked‑up copy of the amended pages.
4. Complete Patents Form 20 (pre‑grant) or apply under Section 27 (post‑grant).
5. File electronically via the UKIPO online services portal, paying any applicable fee.
6. Submit a covering letter explaining the basis for each amendment by reference to specific passages in the application as filed.
7. Await the examiner’s response. If an added‑matter objection is raised, address it with detailed basis argumentation or further narrowing amendments.

EPO Stepwise Checklist

1. Identify the procedural stage: examination, opposition or limitation.
2. Prepare amended claims (and description/drawings if needed) in all three EPO languages where required by the applicable rules.
3. Perform an Article 123(2) disclosure mapping exercise, using the application as filed (including drawings) as the reference document.
4. During examination, file amended pages with a response to the examination report under Rule 71(3) EPC or earlier.
5. During opposition, file the main request and auxiliary requests as complete claim sets, each accompanied by a basis table.
6. For limitation proceedings, file a request under Article 105a EPC with the proposed amended claims and a statement of the grounds for limitation.
7. Monitor the EPO’s communication for any Article 123(2) or 123(3) objection and respond with detailed argumentation within the set time limit.

Sample Timeline Table

Stage	UKIPO (Typical)	EPO (Typical)
Filing to first examination report	12–18 months	18–24 months
Amendment filed in response to exam report	Within deadline set (usually 2–4 months)	Within deadline set (usually 4 months under Rule 132 EPC)
Grant after successful amendment	1–3 months post‑acceptance	3–6 months after decision to grant (Rule 71(3) procedure)
Post‑grant amendment (Section 27 / opposition)	6–18 months (Comptroller application)	12–24 months (opposition); 3–6 months (limitation)

Templates, Sample Wording and Drafting Tips

Effective drafting is the best safeguard against added‑matter objections. The following templates and examples illustrate how to amend patent specification claims and descriptions while minimising risk.

Sample Claim Narrowing (Three Examples)

• Example 1, Combining a dependent claim. Original independent claim: “A pharmaceutical composition comprising compound X.” Dependent claim 3: “The composition of claim 1, wherein compound X is present at a concentration of 0.1–5 % w/v.” Amended independent claim: “A pharmaceutical composition comprising compound X at a concentration of 0.1–5 % w/v.” Risk: Green. The feature is directly imported from a filed claim.
• Example 2, Narrowing by reference to a described embodiment. Original claim: “A method for treating a metabolic disorder.” Description, paragraph [0045]: “In a preferred embodiment, the metabolic disorder is type 2 diabetes.” Amended claim: “A method for treating type 2 diabetes.” Risk: Green, provided “type 2 diabetes” was identified as an independent embodiment and not embedded in a specific combination of features that are not all being imported.
• Example 3, Restricting a numerical range. Original claim: “…at a temperature of 20 °C to 80 °C.” Description, Example 1 conducted at 37 °C. Amended claim: “…at a temperature of 37 °C.” Risk: Amber. The EPO may object that selecting 37 °C as an endpoint was not individually disclosed as significant. The UKIPO is likely to accept this amendment provided the worked example clearly describes this specific temperature.

Description Amendment Template

When amending the description to align with narrowed claims, use the following structure in the covering letter:

“Paragraph [00XX] of the description as filed is hereby amended to read: [new text]. Basis: the amended wording is derived from paragraph [00YY] and claim Z of the application as filed. No new subject‑matter is introduced.”

Wording to avoid in amended descriptions includes phrases such as “it has been surprisingly found that…” or “the inventors have now discovered…”, these suggest new technical information and will attract added‑matter objections. Similarly, avoid importing post‑filing experimental data into the description; this is treated as new matter in virtually all jurisdictions.

For US‑filed counterpart applications, note that the equivalent of a post‑allowance amendment is governed by Rule 312 (37 CFR 1.312) at the USPTO. Unlike the UK or EPO pre‑grant route, a Rule 312 amendment filed after the Notice of Allowance is not entered automatically, it requires a primary examiner’s recommendation. This distinction matters for applicants managing parallel UK, EP and US prosecution strategies.

Next Steps

Knowing how to amend patent specification text is essential for protecting and maximising the value of any patent portfolio. The decision between pre‑grant and post‑grant routes, and between UKIPO and EPO procedures, depends on the stage of the application, the nature of the amendment and the level of added‑matter risk involved. For amendments that are anything other than straightforward claim combinations or obvious error corrections, early specialist advice significantly reduces the risk of refusal, delay or revocation. Practitioners dealing with life‑sciences claims, complex Markush structures or multi‑jurisdictional prosecution should consider instructing experienced patent counsel before filing any amendment request.

Sources

1. Manual of Patent Practice (MOPP), Section 19: General Power to Amend Application Before Grant (GOV.UK)
2. Manual of Patent Practice (MOPP), Section 76: Amendments Not to Include Added Matter (GOV.UK)
3. Patents Act 1977 (legislation.gov.uk)
4. European Patent Convention, Article 123(2) (EPO)
5. EPO Guidelines for Examination (EPO)
6. CIPA, Amendment and Correction Guidance (Chartered Institute of Patent Attorneys)
7. UK Intellectual Property Office, Practice Notices and Guidance (GOV.UK)
8. EPO Boards of Appeal Case Law Database (EPO)
9. Patent Fees and Renewals (GOV.UK)